How is Natalizumab Intravenous Route dosed?
The dosage forms of Natalizumab Intravenous Route are in the form of a solution.
How is Natalizumab Intravenous Route administered?
Natalizumab Intravenous Route is administered through an injection into a vein. It is typically given by a healthcare professional in a hospital or clinic setting. The medicine is used to treat patients with relapsing forms of multiple sclerosis (MS) and moderate to severely active Crohn's disease (CD) when other treatments have not been effective. It is important to note that this medication is available only under a restricted distribution program called the TOUCH Prescribing program. Follow your healthcare provider's instructions regarding dosage and frequency of administration.
What are common precautions when taking Natalizumab Intravenous Route?
Common precautions when taking Natalizumab Intravenous Route include monitoring for side effects such as muscle pain or stiffness, joint pain, stomach soreness or discomfort, swollen glands, trouble concentrating, trouble sleeping, local bleeding, shakiness in the legs, arms, hands, or feet, trembling or shaking of the hands or feet, chest discomfort, and stopping of menstrual bleeding. Report any unusual effects to a healthcare professional. Additionally, Natalizumab may increase the risk of developing infections, including a rare and serious brain infection called progressive multifocal leukoencephalopathy (PML), and may cause a rare condition called immune reconstitution inflammatory syndrome (IRIS). Patients should have their progress checked at 3 months and 6 months after the first injection, and blood and urine tests may be needed to check for unwanted effects.